Massachusetts moves to revoke RegalCare licenses as new oversight rules pass
State health regulators have issued notices to strip licenses from RegalCare facilities after a Boston Globe investigation found care was cut as money went to other businesses. New rules now give the state more power over nursing home owners.
By Standard Topic. AI-generated from the reporting listed under Coverage. Published . Updated .
This story is no longer being updated. It reflects reporting up to .
What happened
Massachusetts health officials are moving to revoke the licenses of a dozen RegalCare nursing homes after a Boston Globe Spotlight report described deteriorating conditions and cost cutting. Officials found RegalCare CEO Eli Mirlis unsuitable to run long-term care facilities, and the state also approved new rules that let regulators scrutinize nursing home owners' finances and records.
Why it matters
The new rules are meant to give the state more authority to act against nursing home operators with poor records in Massachusetts and beyond.
Timeline
- Oct 14, 10:42 AM ET: Health officials ramped up oversight of a dozen RegalCare nursing homes while moving to revoke their licenses after the Boston Globe Spotlight report.
- Oct 14, 2:52 PM ET: Massachusetts adopted regulations strengthening nursing home oversight, and Public Health Commissioner Robbie Goldstein said the state must do better.
- Oct 15, 9:04 AM ET: State officials found RegalCare CEO Eli Mirlis unsuitable to operate long-term care facilities and moved to revoke the licenses under his control.
Coverage
- Opinion | New nursing home regulations just the first step (Boston Globe)
- Massachusetts adopts regulations strengthening nursing home oversight (The New Bedford Light)
- New rules let state scrutinize nursing home owners’ finances, records (wbur.org)
- Mass. regulators tighten nursing home oversight rules (Boston Globe)
- Massachusetts adopts regulations strengthening nursing home oversight (newbedfordlight.org)
More from Health
- Hackensack Meridian Health and Hunterdon Health agree to merge
- Roche signs $15 billion antibody-drug conjugate deal with Hansoh
- Putin's daughter predicts aging breakthroughs within 10 to 20 years
- Cardiologists urged to prescribe exercise for heart patients
- Pennsylvania measles outbreak tops 1,200 as CDC sends investigator
- AstraZeneca enlists Oracle to apply AI in drug trials